Status | Study |
RECRUITING |
Study Name: Study on Trabectedin in Combination With Pioglitazone in Patients Myxoid Liposarcomas With Stable Disease After T Alone. Condition: Liposarcoma, Myxoid Date: 2021-03-03 Interventions: Patients will be treated with Trabectedin administered at a dose of 1.5 mg/m2-1.3mg/m2 (according to investigator's choice, with |
Recruiting |
Study Name: A Pilot Study of NY-ESO-1ᶜ²⁵⁹T Cells in Subjects With Advanced Myxoid/ Round Cell Liposarcoma Condition: Myxoid Round Cell Liposarcoma High Grade Myxoid Liposarcoma Date: 2016-12-12 Interventions: Genetic: Autologous genetically modified T Cells, NY-ESO-1ᶜ²⁵⁹T Cytoreductive che |
Recruiting |
Study Name: Sirolimus and Cyclophosphamide in Metastatic or Unresectable Myxoid Liposarcoma and Chondrosarcoma Condition: Conventional Chondrosarcoma Myxoid Liposarcoma Date: 2016-01-09 Interventions: Drug: sirolimus and cyclophosphamide |
Recruiting |
Study Name: Phase I-II Trial, Multicenter, Open, Exploring Trabectedin Plus Radiotherapy in Soft Tissue Sarcoma Patients Condition: Liposarcoma, Myxoid Sarcoma, Soft Tissue Date: 2014-10-17 Interventions: Drug: Trabectedin Escalating d |
Recruiting |
Study Name: Efatutazone Dihydrochloride in Treating Patients With Previously Treated Myxoid Liposarcoma That Cannot Be Removed by Surgery Condition: Liposarcoma Date: 2014-09-24 Interventions: Drug: efatutazone Given PO |
Recruiting |
Study Name: Dose Reduction of Preoperative Radiotherapy in Myxoid Liposarcomas Condition: Myxoid Liposarcoma of Soft Tissue Date: 2014-03-06 Interventions: Radiation: dose reduction of preoperative radiotherapy in MLS A: The primary sarcoma in case of non-meta |
Recruiting |
Study Name: Recombinant Interferon Gamma in Treating Patients With Soft Tissue Sarcoma Condition: Myxoid Liposarcoma Round Cell Liposarcoma Date: 2013-10-04 Interventions: Other: Laboratory Biomarker Analysis |
Recruiting |
Study Name: Brostallicin Clinical Trial for Myxoid Liposarcoma Condition: Myxoid Liposarcoma Date: 2008-03-03 Interventions: Drug: Brostallicin Patients will receive Brostallicin administered intravenously (IV) over 10 minutes at |
Completed |
Study Name: Safety and Efficacy Study of Trabectedin for the Treatment of Localized Myxoid / Round Cell Liposarcoma Condition: Liposarcoma,Myxoid Date: 2007-12-20 Interventions: Drug: Trabectedin Trabectedin |